Eureka Therapeutics, Inc., a clinical-stage biotechnology company advancing next-generation T-cell therapies for cancer, ...

Initiative Focused on Scaling Advanced Cell and Gene Therapy to Enhance Patient AccessLAKE ZURICH, Ill.--(BUSINESS ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

CAR T-cell therapy is being adapted for clear cell renal cell carcinoma, targeting CAIX and CD70 to improve efficacy and safety. Early trials like COBALT-RCC and TRAVERSE show promising disease ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Strategic acquisition accelerates Title21’s mission to deliver integrated digital solutions for regulated healthcare and life ...

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...

Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP ...

Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.

Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...

NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Rising adoption of cell and gene therapies, along with increasing investments in biopharmaceutical R&D, is accelerating demand for GMP-grade consumables ...

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, " Stem Cell Therapy ...